tm logo
KESIUM
Dead/Abandoned
ABANDONED - NO STATEMENT OF USE FILED

no statement of use filed

on 16 Nov 2020

Last Applicant/ Owned by

10 avenue de la Ballastiére

Libourne

FR

33500

Serial Number

86947363 filed on 21st Mar 2016

Registration Number

N/A

Correspondent Address

William S. Frommer

Haug Partners LLP

745 5TH AVE 10th Floor

NEW YORK, NY 10151-0099

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

KESIUM

Pharmaceutical and veterinary preparations, namely, antimicrobial preparations and substances for use in the treatment of skin infections, urinary tract infections, respiratory tract infections, digestive tract infections, infections of the oral cavity and other infections caused by Beta-lactamase producing strains of bacteria in dogs and cats; chewable tablets containing amoxicillin and clavulaniRead More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical and veterinary preparations, namely, antimicrobial preparations and substances for use in the treatment of skin infections, urinary tract infections, respiratory tract infections, digestive tract infections, infections of the oral cavity and other infections caused by Beta-lactamase producing strains of bacteria in dogs and cats; chewable tablets containing amoxicillin and clavulanic acid for dogs and cats

Mark Details


Serial Number

No 86947363

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 457685-8125

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
16th Nov 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
16th Nov 2020ABANDONMENT - NO USE STATEMENT FILED
18th Mar 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
17th Mar 2020EXTENSION 5 GRANTED
12th Mar 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
04th Mar 2020EXTENSION 5 FILED
04th Mar 2020TEAS EXTENSION RECEIVED
12th Sep 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10th Sep 2019EXTENSION 4 FILED
10th Sep 2019EXTENSION 4 GRANTED